Morgan Stanley Nrx Pharmaceuticals, Inc. Transaction History

Morgan Stanley

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 16, 2024	SELL	$0.29 - $0.7 $111 - $270	-386 Reduced 0.87%	43,948 $20,000
Q1 2024 May 15, 2024	SELL	$0.29 - $0.7 $111 - $270	-386 Reduced 0.87%	43,948 $20,000
Q4 2023 Aug 16, 2024	BUY	$0.26 - $0.47 $11,526 - $20,836	44,334 New	44,334 $20,000
Q4 2023 Feb 13, 2024	SELL	$0.26 - $0.47 $777 - $1,406	-2,992 Reduced 6.32%	44,334 $20,000
Q1 2023 May 15, 2023	SELL	$0.66 - $1.4 $1,987 - $4,216	-3,012 Reduced 5.98%	47,326 $31,000
Q4 2022 Feb 14, 2023	SELL	$0.79 - $9.19 $7,090 - $82,480	-8,975 Reduced 15.13%	50,338 $55,000
Q3 2022 Nov 14, 2022	BUY	$0.2 - $8.07 $589 - $23,790	2,948 Added 5.23%	59,313 $43,000
Q2 2022 Oct 27, 2022	BUY	$0.51 - $2.42 $2,329 - $11,054	4,568 Added 8.82%	56,365 $33,000
Q2 2022 Aug 15, 2022	BUY	$0.51 - $2.42 $2,329 - $11,054	4,568 Added 8.82%	56,365 $33,000
Q1 2022 Oct 27, 2022	SELL	$2.45 - $5.04 $11,191 - $23,022	-4,568 Reduced 8.1%	51,797 $128,000
Q1 2022 May 13, 2022	SELL	$2.45 - $5.04 $13,590 - $27,956	-5,547 Reduced 9.67%	51,797 $128,000
Q4 2021 Feb 14, 2022	BUY	$4.5 - $11.91 $73,314 - $194,037	16,292 Added 39.69%	57,344 $274,000
Q3 2021 Nov 15, 2021	BUY	$8.52 - $24.77 $349,763 - $1.02 Million	41,052 New	41,052 $381,000

17.4K

Ticker NRXP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,641,296
Market Cap $111M
Description
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.